April 2023 in “Research Society and Development” Corticosteroids are safe and effective for treating Alopecia Areata.
COVID-19 may trigger or worsen rapid hair loss in alopecia areata.
April 2023 in “Medizinische Genetik” New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.
January 2023 in “International journal of homoeopathic sciences” The document says homoeopathic treatments are good for hair regrowth in alopecia areata but doesn't give proof.
January 2023 in “International Journal of Pharmaceutical Research and Development” Nanotechnology therapies can help improve quality of life for those with hair loss.
December 2022 in “Rossijskij žurnal kožnyh i veneričeskih boleznej” New treatments for child hair loss due to immune issues are effective but not yet officially approved.
Screening for iron levels in patients with hair loss may help find a genetic iron overload condition early.
September 2022 in “Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica” Skin symptoms appear in up to 20% of Covid-19 cases.
Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.
July 2022 in “Singapore Medical Journal” Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.
June 2022 in “International journal of drug delivery technology” Nebivolol cream may be a promising hair loss treatment by improving blood flow and nourishing hair follicles.
June 2022 in “bioRxiv (Cold Spring Harbor Laboratory)” ILC1-like cells can cause alopecia areata by attacking hair follicles.
May 2022 in “Голова и шея.” Laser exposure at 445±40 nm safely increased tissue temperature without exceeding safety limits.
May 2022 in “Голова и шея.” Online classes worsened students' emotional state, but returning to full-time classes made it worse.
May 2022 in “Голова и шея.” COVID-19-positive patients with prosthetic speech implants face increased risks and need special care.
May 2022 in “Голова и шея.” The physical education program improved students' heart and lung health.
May 2022 in “Голова и шея.” The distal radius evolved to adapt and function despite potential fractures.
May 2022 in “Голова и шея.” Sinus lifting and septoplasty in rats increased sympathetic nervous activity and caused metabolic changes after surgery.
May 2022 in “Голова и шея.” Exosomes show promise for targeted treatment of HER2-positive breast cancer.
May 2022 in “Голова и шея.” Laryngectomy patients need special protection and care during COVID-19 to prevent infection.
May 2022 in “Голова и шея.” Chronic tonsillitis is linked to NETosis activity, which may help tailor treatments and reduce tonsil removal surgeries.
May 2022 in “Голова и шея.” Inflammation from nasal surgery temporarily increases sympathetic nervous system activity, but balance is restored within a week.
May 2022 in “Голова и шея.” Dentists need more awareness about vitamin D3's role in dental implant complications.
May 2022 in “Голова и шея.” Elderly women in Northern Russia have higher anxiety and different brain energy patterns than men.
May 2022 in “Голова и шея.” Essential oils can boost athletic performance by improving brain function and muscle relaxation.
May 2022 in “Голова и шея.” Orthorexia nervosa is not common among people.
May 2022 in “Голова и шея.” Glycolon is the best suture material for tooth extraction surgeries.
May 2022 in “Голова и шея.” Music affects people's brain activity differently based on their musical education.
April 2022 in “Health care of Tajikistan” Managing alopecia areata in children needs a personalized approach considering genetic, immune, and environmental factors.
Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.